Inhibitory effects of bisphosphonate (YM175) on bone resorption induced by a metastatic bone tumor
- 31 January 1996
- Vol. 18 (1) , 1-7
- https://doi.org/10.1016/8756-3282(95)00428-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Bone resorption induced by a metastatic human melanoma cell lineBone, 1995
- Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model systemJournal of Bone and Mineral Research, 1994
- 'Role of bone marrow stromal cells in the growth of human multiple myelomaBlood, 1991
- Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineageJournal of Bone and Mineral Research, 1990
- Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.Journal of Clinical Investigation, 1990
- Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.Journal of Clinical Investigation, 1989
- Cultured Bovine Bone Cells Synthesize Basic Fibroblast Growth Factor and Store It in Their Extracellular MatrixEndocrinology, 1989
- Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)British Journal of Cancer, 1988
- Structure and function of heparan sulphate proteoglycansBiochemical Journal, 1986
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980